Offir Ukashi

MD | Gastroenterology Fellow at Sheba Medical Center | IBD research and innovations. #IBD #Gastroenterology #Research

[Shomron Ben-Horin @ShomronH]

A study by our Drs Tal Engel and @OffirU in @AmJGastro shows that assessment of the same stool consistency by Bristol stool scale is inherently different between IBS pts and doctors.
Better objective tools and candid communication are needed.

https://t.co/pbKbvviv2P

[יואב איתיאל מדווח כי @yoavetiel]

איפה רוני קובן? הנה ד"ר לימור גולדנברג מבנימינה שהלל יפה הודיעו הבוקר שמונתה למנהלת פנימית ב': היא בוגרת הטכניון ומומחית ברפואה פנימית ובפרמקולוגיה קלינית, וגם... בוגרת הנדסת חשמל בטכניון, ואפילו בהצטיינות. @TechnionLive @WallaNews @HILLEL

[UEGJ @UEGJournal]

🧭 #Vedolizumab promotes small-bowel and pan-enteric #healing in #CrohnsDisease

🔸PE-mucosal healing: 15.9% at week 52
🔸SB-healing: 4.5% → 18.2%
🔸Clear reductions in CRP, FCP, Lewis & Eliakim scores
🔸Well tolerated

📖 #OpenAccess 👉https://t.co/fSoZAfcDAX

@my_ueg

[Shomron Ben-Horin @ShomronH]

@JeanFredericCo1 @IBDimmunology @TheLancet Definition of relapse was rather non-standard, and rate of steroid Tx for relapse comparable between arms, as discussed in our Editorial
https://t.co/DrXHxaAGgH

[Shomron Ben-Horin @ShomronH]

Our RCT now in @AGA_Gastro : Pts with #Crohn in remission, who recieved treat-to-target Tx guided by #capsule endoscopy inflammatory assessment, had a significantly lower flare risk over 24m compared to pts continuing standard care
@HelmsleyTrust
https://t.co/kbFgCWvP4x

[alessandro armuzzi @alearmuzzi]

Hot off the press. Inter‐Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five‐Nations Survey Study. @UriKopylov @FernandoMagro6 #henityanai ⁦@OffirU⁩ #5Nationfriendsandparticipants https://t.co/ndtN3KOPwc

[Luis Menchén @lamv50]

Inter‐Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five‐Nations Survey Study. @OffirU https://t.co/tFfZ8ap2DD

[Shomron Ben-Horin @ShomronH]

Study by the 🇮🇪🇪🇦🇵🇹🇮🇱🇨🇵 Five-Nations in @UEGJournal showing that (like most classification systems) actual inter-rater agreement for CD Montreal classification is modest at best. At least LLM and AI models were not much better😉
@UriKopylov
@OffirU
https://t.co/C10hLQhWo7

[Shomron Ben-Horin @ShomronH]

Our talented @Adam_goldman_ found increased intest perforations with JAKi class. Examined in Rheum pts to reduce confounding by IBD.
Caveat of voluntary reporting,but this is how aTNF TB risk was first found, so cant be lightly discarded. @UEGJournal
https://t.co/ey5Ww45Uee

[Shomron Ben-Horin @ShomronH]

FCP is better for colonic > small bowel (SB) inflammatiin, but how accurate is it in proximal vs. distal SB?
Using VCE as gold standard, our
@sheba_medical brilliant fellow @OffirU reports in @JCC_IBD a dilutional gradient of calpro along the SB !
https://t.co/1bizDkwNaG

[Offir Ukashi @OffirU]

@ShomronH @sheba_medical @JCC_IBD Thanks @ShomronH for your kind words and guidance throughout the research!

[Offir Ukashi @OffirU]

@talschneider הציוץ שלך אומלל. במקום להתנצח ולהצטדק יכולה פשוט להתנצל ולחזור בך.. בבחינת ״מודה ועוזב ירוחם״